Dexamethasone regulates endothelin-1 and endothelin receptors in human non-pigmented ciliary epithelial (HNPE) cells

Experimental Eye Research

Volumn 76, Issue 3, 2003, Pages 261-272

  Zhang, Xinyu ^a   Krishnamoorthy, Raghu R ^a   Prasanna, Ganesh ^a   Narayan, Santosh ^a   Clark, Abbot ^b   Yorio, Thomas ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b ALCON RESEARCH LTD   (United States)

Author keywords

Aqueous humour dynamics; Ciliary epithelium; Dexamethasone; Endothelin receptor A; Endothelin receptor B; Endothelin 1; Glucocorticoid receptor; Intraocular pressure; RU486

Indexed keywords

DEXAMETHASONE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; MEMBRANE PROTEIN; MESSENGER RNA; MIFEPRISTONE;

ANTERIOR EYE CHAMBER; AQUEOUS HUMOR FLOW; ARTICLE; CILIARY BODY EPITHELIUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; EYE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INTRAOCULAR PRESSURE; MOLECULAR WEIGHT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; SYNTHESIS; WESTERN BLOTTING;

EID: 0037374514     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4835(02)00323-8     Document Type: Article

References (79)

1. Aitsebaomo J., Kingsley-Kallesen M.L., Wu Y., Quertermous T., Patterson C. Vezf1/DB1 is an endothelial cell-specific transcription factor that regulated expression of endothelin-1 promoter. J. Biol. Chem. 276:2001;39197-39205.
2. Aubert J.D., Juillerat-Jeanneret L., Leuenberger P. Expression of endothelin-1 in human broncho-epithelial and monocytic cell lines: influence of tumor necrosis factor-alpha and dexamethasone. Biochem. Pharmacol. 53:1997;547-552.
3. Beck C.A., Weigel N.L., Moyer M.L., Nordeen S.K., Edwards D.P. The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc. Nat. Acad. Sci. USA. 90:1993;4441-4445.
4. Becker B. Intraocular pressure responses to topical corticosteroids. Invest. Ophthalmol. 4:1965;198-205.
5. Bednar D.L., Stein R.B., Garsky V.M., Williams D.L. The bovine endothelin receptor has an apparent molecular weight of 43,000. Biochem. Biophys. Acta. 1092:1991;226-232.
6. Bolger G.T., Liard F., Krogsrud R., Thibeault D., Jaramillo J. Tissue specificity of endothelin binding sites. J. Cardiovasc. Pharmacol. 16:1990;367-375.
7. Borcsok I., Schairer H.U., Sommer U., Wakley G.K., Schneider U., Geiger F., Niethard F.U., Ziegler R., Kasperk C.H. Glucocorticoids regulate the expression of the human osteoblastic endothelin A receptor gene. J. exp. Med. 188:1998;1563-1573.
8. Bremnes T., Paasche J.D., Mehlum A., Sandberg C., Bremnes B., Attramadal H. Regulation and intracellular trafficking pathways of the endothelin receptors. J. Biol. Chem. 275:2000;17596-17604.
9. Calderon E., Gomez-Sanchez C.E., Cozza E.N., Zhou M., Coffey R.G., Lockey R.F., Prockop L.D., Szentivanyi A. Modulation of endothelin-1 production by a pulmonary epithelial cell line. I. Regulation by glucocorticoids. Biochem. Pharm. 48:1994;2065-2071.
10. Chang T.J., Scher B.M., Waxman S., Scher W. Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation. Mol. Endocrinol. 7:(4):1993;528-542.
11. Cioffi G.A., Sullivan P. The effect of chronic ischemia on the primate optic nerve. Eur. J. Pharm. 9:(1):1999;S34-S36.
12. Clark A.F., Aboul-Ela N., English-Wright S. Microfilament structure and microfilament protein expression in cultured dexamethasone-treated and glaucomatous human trabecular meshwork (TM) cells. Invest. Ophthalmol. Vis. Sci. 38:1997;S489.
13. Clark A.F., Steely H.T., Dickerson J.E. Jr, English-Wright S., Stropki K., McCartney M.D., Jacobson N., Shepard A.R., Clark J.I., Matsushima H., Peskind E.R., Leverenz J.B., Wilkinson C.W., Swiderski R.E., Fingert J.H., Sheffield V.C., Stone E.M. Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. Invest. Ophthalmol. Vis. Sci. 42:2001;1769-1780.
14. 1 pig kidney cells? Biochem. Mol. Biol. Int. 39:1996;581-588.
15. Erickson-Lamy K., Korbmacher C., Schuman J.S., Nathanson J.A. Effect of endothelin on outflow facility and accommodation in the monkey eye in vivo. Invest. Ophthalmol. Vis. Sci. 32:1991;492-495.
16. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
17. Freedman N.J., Ament A.S., Oppermann M., Stoffel R.H., Exum S.T., Lefkowitz R.J. Phosphorylation and desensitization of human endothelin A and B receptors: evidence for G protein-coupled receptor kinase specificity. J. Biol. chem. 272:1997;17734-17743.
18. Granstam E., Wang L., Bill A. Effects of endothelins (ET-1, ET-2, and ET-3) in the rabbit eye: role of prostaglandins. Eur. J. Pharmacol. 194:1991;217-223.
19. Gotoh T., Chowdhury S., Takiguchi M., Morin M. The glucocorticoid- responsive gene cascade: activation of the rat arginase gene through induction of C/EBPbeta. J. Biol. Chem. 272:1997;3694-3698.
20. Johnson D.H., Bradley J.M.B., Acott T.S. The effect of dexamethasone on glycosaminoglycans of human trabecular meshwork in perfusion organ cultured. Invest. Ophthalmol. Vis. Sci. 31:1990;2568-2571.
21. Johnson D.H., Gottanka J., Flugel C., Hoffman F., Futa R., Lutjen-Drecoll E. Ultrastructural changes in the trabecular meshwork of human eyes treated with glucocorticoids. Arch. Ophthalmol. 115:1997;375-383.
22. Jonat C., Rahmsdorf H.J., Park K.K., Cato A.C., Gebel S., Ponta H., Herrlich P. Antitumor promotion and antiinflammation: down-regulation of AP-1 (fos/Jun) activity by glucocorticoid hormone. Cell. 62:1990;1189-1204.
23. Kakinuma Y., Miyauchi T., Yuki K., Murakoshi N., Goto K., Yamaguchi I. Novel molecular mechanism of increased myocardial endothelin-1 expression in the failing heart involving the transcriptional factor hypoxia-inducible factor-1 alpha induced for impaired myocardial energy metabolism. Circulation. 103:2001;2387-2394.
24. Kallberg M.E., Brooks D.E., Garcia-Sanchez G.A., Komaromy A.M., Szabo N.J., Tian L. Endothelin1 levels in the aqueous humour of dogs with glaucoma. J. Glaucoma. 11:2002;105-109.
25. Kanse S.M., Takahashi K., Warren J.B., Ghatei M., Bloom S.R. Glucocorticoids induce endothelin release from vascular smooth muscle cells but not endothelial cells. Eur. J. Pharm. 199:1991;99-101.
26. C receptor) from Xenopus laevis dermal melanophores. J. Biol. Chem. 268:1993;19126-19133.
27. Kato H., Hayashi T., Koshino Y., Oida K., Kutsumi Y., Nakai T., Miyabo S. Autocrine production of endothelin-1 participates in the glucocorticoid-induced Ca2+ influx into vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 208:1995;82-88.
28. Kondoh M., Miyazaki H., Watanabe H., Shibata T., Yanagisawa M., Masaki T., Murakami K. Isolation of anti-endothelin receptor monoclonal antibodies for use in receptor characterization. Biochem. Biophys. Res. Commun. 172:1990;503-510.
29. Kurokawa K., Yamada H., Ochi J. Topographical distribution of neurons containing endothelin type A receptor in the rat brain. J. Comp. Neurol. 389:1997;348-360.
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
31. Lee M.E., Bloch K.D., Clifford J.A., Quertermous T. Functional analysis of the endothelin-1 gene promoter. Evidence for an endothelial cell-specific cis-acting sequence. J. Biol. Chem. 265:1990;10446-10450.
32. Lepple-Weinheus A., Becker M., Stahl F., Berweck S., Hensen J. Endothelin-like immunoreactivity in the aqueous humour and in conditioned medium from ciliary epithelial cells. Curr. Eye Res. 10:1992;983-989.
33. Lewis J.M., Priddy T., Judd J., Gordon M.O., Kass M.A., Kolker A.E., Becker B. Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open-angle glaucoma. Am. J. Ophthalmol. 106:1988;607-612.
34. Liu Z., Auboeuf D., Wong J., Chen J.D., Tsai S.Y., Tsai M.J., O'Malley B.W. Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486. Proc. Nat. Acad. Sci. USA. 99:2002;7940-7944.
35. Martin-Vasallo P., Gnosh S., Coca-Prados M. Expression of Na, K-ATPase alpha subunit isoforms in the human ciliary body and cultured ciliary epithelial cells. J. Cell. Physiol. 141:1989;243-252.
36. Masuda Y., Miyazaki H., Kondoh M., Watanabe H., Yanagisawa M., Masaki T., Murakami K. Two different forms of endothelin receptors in rat lung. FEBS Lett. 257:1989;208-210.
37. McCartney M.D., Wilson K., Miggans S.T., Clark A.F. Effect of dexamethasone and tetrahydocortisol on cultured human trabecular meshwork cell microfilament and microtubule structure. Invest. Ophthalmol. Vis. Sci. 35:1994;S2735.
38. McCarty G.R., Schwartz B. Increased concentration of glucocorticoid receptors in rabbit iris-ciliary body compared to rabbit liver. Invest. Ophthalmol. Vis. Sci. 23:1982;525-528.
39. McCarty G.R., Schwartz B. Increased plasma noncortisol glucocorticoid acitvity in open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 32:1991;1600-1608.
40. Morin C., Asselin C., Boudreau F., Provencher P.H. Transcriptional regulation of pre-pro- endothelin-1 gene by glucocorticoids in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 244:1998;583-587.
41. Neufeld A.H. Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma. Surv. Ophthalmol. 43:1999;S129-S135.
42. Noske W., Hensen J., Wiederholt M. Endothelin-like immunoreactivity in aqueous humour of primary open-angle glaucoma and cataract patients. Grafes Arch. Clin. Exp. Ophthalmol. 235:1997;551-552.
43. Omichinski J.G., Clore G.M., Schaad O., Felsenfeld G., Trainor C., Appella E., Stahl S.J., Gronenborn A.M. NMR structure of a specific DNA complex of Zn-containing DNA binding domain of GATA-1. Science. 261:1993;438-446.
44. Orgul S., Cioffi G.A., Wilson D.J., Bacon D.R., Van Buskirk E.M. An endothelin-1 induced model of optic nerve ischemia in the rabbit. Invest. Ophthalmol. Vis. Sci. 37:1996;1860-1869.
45. Paasche J.D., Attramadal T., Sandberg C., Johansen H.K., Attramadal H. Mechanisms of endothelin receptor subtype-specific targeting to district intracellular trafficking pathways. J. Biol. Chem. 276:2001;34041-34050.
46. Pang I.H., Yorio T. Ocular actions of endothelins. Proc. Soc. Exp. Biol. Med. 215:1997;21-34.
47. Polansky J.R., Fauss D.J., Chen P., Chen H., Lutjen-Drecoll E., Johnson D., Kurtz R.M., Ma Z.D., Bloom E., Nguyen T.D. Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica. 211:1997;126-139.
48. Prasanna G., Dibas A., Tao W., White K., Yorio T. Regulation of endothelin-1 in human non-pigmented ciliary epithelial cells by tumor necrosis factor-α Exp. Eye Res. 66:1998;9-18.
49. Prasanna G., Krishnamoorthy R., Hulet C., Zhang H., Zhang X., Yorio T. Endothelin-1 induces nitric oxide synthase-2 expression in human non-pigmented ciliary epithelial cells. Exp. Eye Res. 71:2000;535-539.
50. Prasanna G., Dibas A., Hulet C., Yorio T. Inhibition of Na(+)/K(+)-ATPase by endothelin-1 in human nonpigmented ciliary epithelial cells. J. Pharmacol. Exp. Ther. 296:2001;966-971.
51. Provencher P.H., Saltis J., Funder J.W. Glucocorticoids but not mineralocorticoids modulate endothelin-1 and angiotensin II binding in SHR vascular smooth muscle cells. J. Steroid Biochem. Mol. Biol. 52:1995;219-225.
52. Raich N., Romeo P.H. Erythroid regulatory elements. Stem Cells. 11:1993;95-104.
53. Ray A., Prefontaine K.E. Physical association and functional antagonism between the p65 subunit or transcription factor NF-κB and the glucocorticoid receptor. Proc. Nat. Acad. Sci. 91:1994;752-756.
54. Ray S., Mehra K.S., Misra S., Singh R. Plasma cortisol in glaucoma. Ann. Ophthalmol. 9:1977;1151-1154.
55. Ripodas A., De Juan J.A., Moya F.J., Fernandez-Cruz A., Fernandez-Durango R. Identification of endothelin receptor subtypes in rat ciliary body using subtype-selective ligands. Exp. Eye Res. 66:1998;69-79.
56. Roubert P., Viossat I., Lonchampt M.O., Chapelat M., Schulz J., Plas P., Gillard-Roubert V., Chabrier P.E., Braquet P. Endothelin receptor regulation by Endothelin synthesis in vascular smooth muscle cells: effects of dexamethasone and phosphoramidon. J. Vasc. Res. 30:1993;139-144.
57. Rozsival P., Hampl R., Obenberger J., Starka L., Rehak S. Aqueous humour and plasma cortisol levels in glaucoma and cataract patients. Curr. Eye Res. 1:1981;391-396.
58. Rubanyi G.M., Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46:1994;325-415.
59. Samples J.R., Alexander J.P., Acott T.S. Regulation of the levels of human trabecular meshwork matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone. Invest. Ophthalmol. Vis. Sci. 34:1993;3386-3395.
60. Sartorius C.A., Groshong S.D., Miller L.A., Powell R.L., Tung L., Takimoto G.S., Horwitz K.B. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res. 54:1994;3868-3877.
61. Scatchard G. The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. 51:1949;660-672.
62. Schulz M., Eggert M., Baniahmad A., Dostert A., Heinzel T., Renkawitz R. RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding. J. Biol. Chem. 277:2002;26238-26243.
63. Schwartz B., McCarty G., Rosner B. Increased plasma free cortisol in ocular hypertension and open angle glaucoma. Arch. Ophthalmol. 105:1987;1060-1065.
64. Shannon T.R., Hale C.C. Identification of a 65 kDa endothelin receptor in bovine cardiac sarcolemmal vesicles. Eur. J. Pharm. 267:1994;233-238.
65. Shepard A.R., Jacobson N., Fingert J.H., Stone E.M., Sheffield V.C., Clark A.F. Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 42:2001;3173-3181.
66. Snyder R.W., Stamer W.D., Kramer T.R., Seftor R.E.B. Corticosteroid treatment and trabecular meshwork proteases in cell and organ culture supernatants. Exp. Eye Res. 57:1993;461-468.
67. Steely H.T., Browder S.L., Julian M.B., Miggans S.T., Wilson K.L., Clark A.F. The effects of dexamethsone on fibronection expression in cultured human trabecular meshwork cell. Invest. Ophthalmol. Vis. Sci. 33:1992;2242-2250.
68. Strokes J., Noble J., Brett L., Phillips C., Seckl J.R., O'Brien C., Andrew R. Distribution of glucocorticoid and mineralocorticoid receptors and 11β-hydroxysteroid dehydrogenases in human and rat ocular tissues. Invest. Ophthalmol. Vis. Sci. 41:2000;1629-1638.
69. B receptor, and cyclooxygenase products in rabbits. Curr. Eye Res. 14:1995;479-486.
70. Takasuka T., sakurai T., Goto K., Furuichi Y., Watanabe T. Human endothelin receptor ETB. J. Biol. Chem. 269:1994;7509-7513.
71. Taniguchi T., Haque M.S.R., Sugiyama K., Okada K., Nakai Y., Kitanawa Y. Effects of endothelin A and B receptors on aqueous humour dynamics in the rabbit eye. J. Ocul. Pharmacol Ther. 12:1996;123-130.
72. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Nat. Acad. Sci. USA. 76:1979;4350-4354.
73. Underwood J.L., Murphy C.G., Chen J., Franse-Carman L., Wood I., Epstein D.L., Alvarado J.A. Glucocorticoids regulate transendothelial fluid flow resistance and formation of intercellular junctions. Am. J. Physiol. 277:1999;C330-C342.
74. Wiederholt M. Nitric oxide and endothelin in aqueous humour outflow regulation. Haefliger I., Flammer J. Nitric Oxide and Endothelin in the pathogenesis of Glaucoma. 1998;168-177 Lippincott-Raven, Philadelphia, PA.
75. Wilson K., McCartney M.D., Miggans S.T., Clark A.F. Dexamethasone induced ultrastructural changes in cultured human trabecular meshwork cells. Curr. Eye Res. 12:1993;783-793.
76. Wordinger R.J., Clark A.F. Effects of glucocorticoid on the trabecular meshwork: towards a better understanding of glaucoma. Retinal Eye Res. 18:1999;629-667.
77. Yamashita K., Discher D.J., Hu J., Bishopric N.H., Webster K.A. Molecular regulation of the endothelin-1 gene by hypoxia, Contributions of hypoxia- inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. J. Biol. Chem. 276:2001;12645-12653.
78. Yorio T., Krishnamoorthy R., Prasanna G. Endothelin: is it a contributor to glaucoma pathophysiology? J. Glaucoma. 11:2002;259-270.
79. Zolk O., Quattek J., Sitzler G., Schrader T., Nickenig G., Schnabel P., Shimada K., Takahashi M., Bohm M. Expression of endothlin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure. Circulation. 99:1999;2118-2123.